scorecardresearch
Follow Us:
Wednesday, November 25, 2020

New research: Arthritis drug may offer hope for older Covid-19 patients

Using artificial intelligence, Imperial team initially identified it as a drug that could have antiviral and anti-inflammatory effects.

By: Express News Service | New Delhi | Updated: November 17, 2020 1:08:49 pm
A runner passes by a window displaying portraits of people wearing face coverings to help prevent the spread of the coronavirus, Monday, Nov. 16, 2020, in Lewiston, Maine. (AP Photo: Robert F. Bukaty)

An existing type of arthritis drug may reduce the risk of dying for elderly patients with Covid-19, according to an international study, led by scientists at Imperial College London and the Karolinska Institutet, Sweden, and published in the journal Science Advances.

The drug, baricitinib, is usually used to treat rheumatoid arthritis.

Using artificial intelligence, Imperial team initially identified it as a drug that could have antiviral and anti-inflammatory effects. 📣 Express Explained is now on Telegram

In the early-stage international study, 83 patients with moderate to severe Covid-19 infection were given the drug. They were in multiple hospitals across Italy and Spain. Those given the drug were found to have a 71 per cent reduced risk of dying compared to patients who had not taken the drug.

The study also found that 17 per cent of patients who were given the drug died or needed to go on a ventilator, compared to 35 per cent in the control group who were not given the medication.

The research team said the findings are being followed up with largescale clinical trials.

Source: Imperial College London

x

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Explained News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement